IDDI complimentary webinar on characteristics of Covid-19 trials and impact of the pandemic on clinical trials
The current SARS-CoV-2-induced coronavirus 2019 (COVID-19) pandemic has called for urgent design and implementation of clinical trials against this potentially life-threatening infection. The pandemic has also had a tremendous impact on ongoing clinical trials for all other indications. In both cases, the crisis has highlighted several limitations that currently exist and hinder a more agile and pragmatic, but at the same time ethically and scientifically sound, clinical-trials enterprise.
Key Takeaways:
- The key characteristics of COVID-19 trials, particularly with regard to trial-design features such as trial mechanics (including factorial and multi-stage designs, as well as platform trials), outcome assessment, and other important methodological issues.
- The impact the pandemic is having on clinical trials in several fields, including oncology and cardiology.
- Practical issues pertaining to trial design and conduct, including for data capture, data management, statistical analysis, and patient follow-up, all of which affected by the current crisis.
Speakers:
View the Presentation
Fields marked with an * are required.
